Dapoxetine clinical trials
How each study uses dapoxetine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
13 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (4) · Alza Corporation, DE, USA (3) · SK Chemicals Co., Ltd. (2) · Janssen Research & Development, LLC (1) · Sohag University (1) · Yuhan Corporation (1) · Yan-Ping Huang (1) · Xidian University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses dapoxetine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation TherapyCompletedPhase 3Janssen Research & Development, LLCNCT01063881Written as DapoxetineHow we know
- Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile DysfunctionStatus unknownPhase 3Yan-Ping HuangNCT04361305Written as DapoxetineHow we know
- Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature EjaculationCompletedPhase 3Sohag UniversityNCT04085354Written as DapoxetineHow we know
- Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation PatientsStatus unknownNot applicableXidian UniversityNCT03583112Written as Dapoxetine Hydrochloride TabletHow we know
- Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mgCompletedPhase 1SK Chemicals Co., Ltd.NCT02485041Written as Dapoxetine 30mgHow we know
- Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mgCompletedPhase 1SK Chemicals Co., Ltd.NCT02485028Written as Dapoxetine 30mg tabletHow we know
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and DapoxetineStatus unknownPhase 1Dong-A Pharmaceutical Co., Ltd.NCT01928563Written as DapoxetineHow we know
- Concomitant Use of PriLigy in Men Treated for Erectile DysfunctionCompletedPhase 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT01063855Written as DapoxetineHow we know
- Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044CompletedPhase 1/2Yuhan CorporationNCT01419470Written as dapoxetineHow we know
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedPhase 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00229073Written as dapoxetineHow we know
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedPhase 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00210704Written as DapoxetineHow we know
- A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature EjaculationCompletedPhase 3Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT00210613Written as DapoxetineHow we know
- An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid EjaculationCompletedPhase 3Alza Corporation, DE, USANCT01230762Written as dapoxetineHow we know
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.CompletedPhase 3Alza Corporation, DE, USANCT00211107Written as DapoxetineHow we know
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedPhase 3Alza Corporation, DE, USANCT00211094Written as DapoxetineHow we know
As the comparator · 2 — what is tested is compared with dapoxetine
- On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature EjaculationCompletedPhase 2/3Benha UniversityNCT07081659Written as dapoxetine 60mgHow we know
- The Impact and Benefit of Physical Activity on Premature EjaculationCompletedNot applicableAnkara Training and Research HospitalNCT02844998Written as dapoxetine 30 mg on demandHow we know
Codes
What other systems call dapoxetine · ClinicalTrials.gg INT003720
- MeSH (NLM) C080598dapoxetineOne source NLM
- UNII (FDA) GB2433A4M3DAPOXETINEConfirmed FDA, NLM, Wikidata
- Wikidata Q424965dapoxetineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75168DapoxetineOne source FDA
- DrugBank DB04884One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C080598 | dapoxetine | One source NLM |
| UNII (FDA) | GB2433A4M3 | DAPOXETINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q424965 | dapoxetine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75168 | Dapoxetine | One source FDA |
| DrugBank | DB04884 | — | One source Wikidata |
Also registered as dapoxetine hydrochloride (UNII U4OHT63MRI).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.